防治葸环类抗肿瘤药物心脏毒性的中国专家共识(2011版)
作者：中国临床肿瘤学会(CSCO)， 中华血液学会， 哈尔滨血液病肿瘤研究所
作者单位：
刊名：
临床肿瘤学杂志
英文刊名：Chinese Clinical Oncology
年，卷(期)：2011,16(12)
参考文献(33条)
1.Lipshultz SE;Colan SD;Gelber RD Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood[外文期刊] 1991(12)
2.Gabizon A;Martin F Polyethylene glycol-coated (pegylated) liposomal doxorubicin.Rationale for use in solid tumours 1997(Suppl 4)
3.Lipshultz SE;Giantris AL;Lipsitz SR Doxorubicin administration by continuous infusion is not
cardioprotective:the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol[外文期刊] 2002(06)
4.曾令源;李晓昕;付彬玉注射用右丙亚胺对阿霉素引起的心脏毒性的保护作用[期刊论文]-药学与临床研究 2008(06)
5.Lipshultz SE;Rifai N;Dalton VM The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia[外文期刊] 2004(02)
6.Lipshultz SE;Lipsitz SR;Sallan SE Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia 2005(12)
7.Seidman A;Hudis C;Pierri MK Cardiac dysfunction in the trastuzumab clinical trials experience[外文期刊]
2002(05)
8.Lebrecht D;Kokkori A;Ketelsen UP Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin[外文期刊] 2005(04)
9.Lebrecht D;Setzer B;Ketelsen UP Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy[外文期刊] 2003(19)
10.Wallace KB Doxorubicin-induced cardiac mitochondrionopathy[外文期刊] 2003(03)
11.Ito H;Miller SC;Billingham ME Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro[外文期刊] 1990(11)
12.Hershko C;Pinson A;Link G Prevention of anthracycline cardiotoxicity by iron chelation[外文期刊] 1996(01)
13.(S)imtùnek T;(S)tirba M;Popelová O Anthracycline-induced cardiotoxicity:overview of studies examining the roles of oxidative stress and free cellular iron[外文期刊] 2009(01)
14.胡莎;贾苍松蒽环类抗肿瘤药物的心脏毒性[期刊论文]-中国小儿血液与肿瘤杂志 2009(02)
15.Minotti G;Menna P;Salvatorelli E Anthracyclines:molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[外文期刊] 2004(02)
16.Lipshultz SE;Rifai N;Sallan SE Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury 1997(08)
17.邵维维;邵宗鸿蒽环类药物的心脏毒性及防治进展[期刊论文]-中国实用内科杂志 2008(09)
18.Ganame J;Claus P;Uyttebroeck A Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients[外文期刊] 2007(12)
19.Swain SM;Whaley FS;Ewer MS Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trials[外文期刊] 2003(11)
20.Von Hoff DD;Layard MW;Basa P Risk factors for doxorubicin-induced congestive heart failure 1979(05)
21.Cvetkovi'c RS;Scott LJ Dexrazoxane:a review of its use for cardioprotection during anthracycline chemotherapy
[外文期刊] 2005(07)
22.李文瑜;费洪文;陆泽生无创监测表阿霉素心脏毒性一组织多普勒超声心动图[期刊论文]-中国病理生理杂志 2006(10)
23.Marchandise B;Schroeder E;Bosly A Early detection of doxorubicin cardiotoxicity:interest of Doppler echocardiographic analysis of left ventricular filling dynamics[外文期刊] 1989(01)
24.Berry GJ;Jorden M Pathology of radiation and anthracycline cardiotoxicity[外文期刊] 2005(07)
25.Marty M;Espie' M;Llombart A Multicenter randomized phase Ⅲ study of the cardioprotective effect of dexrazoxane (cardioxane_) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy[外文期刊] 2006(04)
26.Barry E;Alvarez JA;Scully RE Anthracycline-induced cardiotoxicity:course,pathophysiology,prevention and management[外文期刊] 2007(08)
27.Junjing Z;Yan Z;Baolu Z Scavenging-effects of dexrazoxane on free radicals[外文期刊] 2010(03)
28.赵先英;张涛;刘毅敏右丙亚胺对蒽环类抗肿瘤抗生素心脏保护作用的研究进展[期刊论文]-癌症 2001(04)
29.van Dalen EC;Caron HN;Dickinson HO Cardioprotective interventions for cancer patients receiving anthracyclines 2011(02)
30.Bovelli D;Plataniotis G;Roila F Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease:ESMO Clinical Practice Guidelines 2010(Suppl 5)
31.Meinardi MT;van Veldhuisen DJ;Gietema JA Prospective evaluation of early cardiac damage induced by epirubicincontaining adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients[外文期刊] 2001(10)
32.Nousiainen T;Jantunen E;Vaaninen E Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma[外文期刊] 1999(02)
33.Venturini M;Michelotti A;Mastro LD Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer 1996(12)
本文链接：https://www.doczj.com/doc/bf8050433.html,/Periodical_lczlxzz201112017.aspx